Global Rat Model Market to Reach $2.41 Billion by 2030 with a CAGR of 7.06%: Key Insights and Growth Factors Unveiled

DUBLIN, Oct. 31, 2023 /PRNewswire/ — The “Rat Model Market Size, Share & Trends Analysis Report By Type (Outbred, Knockout), By Technology (Embryonic Stem Cell, Microinjection), By Service, By Application, By End-use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global rat model market size is expected to reach USD 2.41 billion by 2030., expanding at a CAGR of 7.06% from 2023 to 2030. Genetically modified organisms are extensively used in research for identifying potential therapeutic targets and further validation of the same. The extensive healthcare-based research has driven the market for understanding diseases and genetic illnesses of humans.

During the COVID-19 outbreak, researchers were focused on understanding the pathogenesis and transmission of the SARS-CoV2 virus by using the readily available animal model in addition to in-vitro and ex-vivo culture systems. These models also helped in the evaluation of vaccines and antivirals for the treatment. Companies creating transgenic animals used this as a perfect opportunity to provide the scientific community with genetically modified rats for evaluation of SARS-Cov2 entry. For example, in 2020, Envigo created the hACE2 knockinrat model through CRISPR-based technology. ACE2 serving as a primary receptor facilitates the entry of the SARS-CoV2 virus and is being investigated as a potential preventative target.

Animal models continue to be significant tools for preclinical testing of potential therapeutics and understanding disease mechanisms. Increased spending on research and growing number of clinical trials are the key factors contributing to the market growth. The rising incidence of genetic diseases globally and the surge in the use of animal species to advance various groundbreaking therapies are expected to further propel the market growth. Post completion of The Human Genome Project in 2003, there have been evident advancements in synthetic and molecular biology for understanding the genetic basis of diseases. These advanced technologies and products have also made it easier to create genetically engineered models (GEM) of rats, wherein different types such as knockout, outbred, inbred, and conditioned are now available in the market.

The market is expected to observe direct competition from the mouse/mice model. The mice models have been long preferred due to their small sizes and they offer economic as well as more established choices for discovery and early stage research. However, the vast use of gene editing tools in rats and the similarity of rat and human genomes make the rat model suitable for genetic manipulation and handling of experiments, thus fueling the market expansion.

Rat Model Market Report Highlights

By type, outbred rat held the largest share in 2022. This is due to the physiological similarity of gene changes in outbred rats as in humans, which attributes to a disease phenotypeBy technology, other technologies (CRISPR/Cas, ZFN, and more)accounted for the largest share in 2022. The advent of genome editing tools has led to custom rat model creation according to the research application, thus contributing to the market demandBy service, the breeding segment dominated the market in 2022. This is due to the high demand for multiple rat models during experiments to assess genetic variations among a population poolBy application, in 2022, toxicology held the largest share. Owing to the demand for medications and therapeutics, toxicology studies in rats help analyze various factors such as dosing and route of administration during preclinical stagesBy end-use, the contract research organizations held the largest share in 2022. The robust R&D settings and the multiple drug discovery programs and clinical trials are fueling the segment growth. These activities employ a wide number of rat models to mimic the human response during any treatmentNorth America held the largest revenue share in 2022. Growing prevalence of diseases in this region, coupled with the focus of healthcare agencies on this, has resulted in multiple funding to academic institutes for facilitating research in rats

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Rat Model Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Rat Model Market Analysis Tools

Chapter 4. Rat Model: Type Estimates & Trend Analysis

Chapter 5. Rat Model: Technology Estimates & Trend Analysis

Chapter 6. Rat Model: Service Estimates & Trend Analysis

Chapter 7. Rat Model: Application Estimates & Trend Analysis

Chapter 8. Rat Model: End-use Estimates & Trend Analysis

Chapter 9. Rat Model Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/navcpj

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-rat-model-market-to-reach-2-41-billion-by-2030-with-a-cagr-of-7-06-key-insights-and-growth-factors-unveiled-301972699.html

SOURCE Research and Markets